Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia-Reference-Cited by-同舟云学术

Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

Published:2017-04-20 Issue:16 Volume:376 Page:1540-1550
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Townsley Danielle M.,Scheinberg Phillip,Winkler Thomas,Desmond Ronan,Dumitriu Bogdan,Rios Olga,Weinstein Barbara,Valdez Janet,Lotter Jennifer,Feng Xingmin,Desierto Marie,Leuva Harshraj,Bevans Margaret,Wu Colin,Larochelle Andre,Calvo Katherine R.,Dunbar Cynthia E.,Young Neal S.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1613878

Cited by 413 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study;eClinicalMedicine;2024-10

2. Adding eltrombopag to intensive immunosuppressive therapy helps adult patients catch up pediatric patients in severe aplastic anemia;2024-09-10

3. The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia;Annals of Hematology;2024-09-05

4. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP);Blood Cells, Molecules, and Diseases;2024-09

5. Trilineage hematopoietic recovery with romiplostim in a child with down syndrome and aplastic anemia: A case report and review of literature;Pediatric Hematology Oncology Journal;2024-09